Monte Rosa Therapeutics Inc

GLUE USD0.0001
Create an alert
Sell$14.76
Buy$14.77
$0.92 (5.83%)
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
16 July 2026
Markus WarmuthPresident/CEO
Sell
Regular sell transaction (market)
9,500$23.18$220,218.55585,038
15 July 2026
Jennifer ChampouxCOO
Sell
Option/Award related
4,351$23.38$101,729.8662,371
6 July 2026
Sharon TownsonChief Level Officer
Sell
Option/Award related
5,600$23.25$130,197.2068,245
6 July 2026
Sharon TownsonChief Level Officer
Sell
Option/Award related
400$24.13$9,652.0067,845
30 June 2026
Filip JankuOther Level A
Sell
Option/Award related
5,407$24.50$132,471.5060,612
29 June 2026
Filip JankuOther Level A
Sell
Option/Award related
6,000$22.95$137,700.0059,992
29 June 2026
Anthony M (Tony) ManningDirector
Sell
Option/Award related
10,000$23.11$231,100.000
24 June 2026
Filip JankuOther Level A
Sell
Option/Award related
30,000$21.42$642,681.0059,992
23 June 2026
Sharon TownsonChief Level Officer
Sell
Option/Award related
3,000$20.00$60,000.0067,845
23 June 2026
Jennifer ChampouxCOO
Sell
Option/Award related
2,175$20.00$43,500.0062,371

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
24 June 2026
Filip JankuOther Level A
Sell
Option/Award related
30,000$21.42$642,681.0059,992
27 February 2026
Edmund (Ed) DunnChief Accounting Officer
Sell
Option/Award related
25,164$18.10$455,506.1522,693
23 June 2026
Filip JankuOther Level A
Sell
Regular sell transaction (market)
11,845$20.22$239,522.4859,992
29 June 2026
Anthony M (Tony) ManningDirector
Sell
Option/Award related
10,000$23.11$231,100.000
16 July 2026
Markus WarmuthPresident/CEO
Sell
Regular sell transaction (market)
9,500$23.18$220,218.55585,038

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.